Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy of Fluviral™ Influenza Vaccine in Healthy Adults 18 to 49 Years of Age

NCT00216242 is registered in ClinicalTrials.gov with ID Biomedical Corporation, Quebec as lead sponsor.

NCT NCT00216242
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00216242 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy of Fluviral™ Influenza Vaccine in Healthy Adults 18 to 49 Years of Age
Lead sponsor
ID Biomedical Corporation, Quebec
Phase
Phase 3
Overall status
Unknown status
Start date
September 30, 2005
Completion date
May 31, 2007
Enrollment
7,400
Sites
43

Conditions

As the registry lists them; a condition with its own page is linked.

influenza